# AScVS and/ or Prazosin for Scorpion Envenomation

> **NCT00753064** · PHASE3 · COMPLETED · sponsor: **Haffkine Bio-Pharmaceutical Corporation Ltd.** · enrollment: 81 (actual)

## Conditions studied

- Scorpion Envenomation

## Interventions

- **DRUG:** Antiscorpion venom serum(AScVS).
- **DRUG:** T.Prazosin
- **DRUG:** AScVS + Prazosin

## Key facts

- **NCT ID:** NCT00753064
- **Lead sponsor:** Haffkine Bio-Pharmaceutical Corporation Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2008-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00753064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00753064, "AScVS and/ or Prazosin for Scorpion Envenomation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00753064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*